Protalix BioTherapeutics Inc (AMEX:PLX) traded at $1.41 at close of the session on Friday, July 11 and made a downward move of -4.73% on its previous day’s price. Looking at the stock we see that its previous close was $1.48 and the beta (5Y monthly)
Protalix BioTherapeutics Inc (AMEX:PLX) price closed lower on Monday, June 30, and dropping -3.90% below its previous close. A look at the daily price movement shows that the last close reads $1.54, with intraday deals fluctuated between $1.43 and $1.6. The company’s 5Y monthly beta
Protalix BioTherapeutics Inc (AMEX:PLX) concluded the trading at $1.58 on Friday, June 06 with a rise of 3.95% from its closing price on previous day. Company’s P/E ratio for the trailing 12 months is 37.62. Considering stock’s 52-week price range provides that PLX hit a
Protalix Bio Therapeutics, Inc. (PLX) stock soared 46.67% in the pre-market trading session at the price of $1.54 after reporting topline data from the BALANCE clinical trial evaluating PRX–102. PLX is a biopharmaceutical firm that develops and commercializes therapeutic proteins using its plant cell-based ProCellEx
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.